MMP14 and breast carcinoma: Weise et al., using an established breast cancer cell line, proved the wide contribution of MT1-MMP as well as MT2-MMP to the invasive activity of cancer cells into vessels and basement membranes with their proteolytic activity against collagens, leading to the degradation of ECMs [73].